FTY720 on the way from the base camp to the summit of the mountain: relevance for remyelination (Q37989903)

26 August 2017

FTY720 on the way from the base camp to the summit of the mountain: relevance for remyelination (English)

1 reference

26 August 2017

M Kipp

1

1 reference

PubMed ID

22383435

26 August 2017

S Amor

series ordinal

2

1 reference

PubMed ID

22383435

26 August 2017

language of work or name

1 reference

1 March 2012

1 reference

Multiple Sclerosis Journal

26 August 2017

1 reference

26 August 2017

18

1 reference

26 August 2017

3

1 reference

26 August 2017

258-263

1 reference

Cell surface receptors in lysophospholipid signaling

26 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Prevention and cure of autoimmune diabetes in nonobese diabetic mice by continuous administration of FTY720.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

FTY720 ameliorates MOG-induced experimental autoimmune encephalomyelitis by suppressing both cellular and humoral immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Edg8/S1P5: an oligodendroglial receptor with dual function on process retraction and cell survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Essential roles of sphingosine 1-phosphate/S1P1 receptor axis in the migration of neural stem cells toward a site of spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Sphingosine kinase 1/S1P receptor signaling axis controls glial proliferation in mice with Sandhoff disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Essential role for sphingosine kinases in neural and vascular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Sphingosine and sphingosine 1-phosphate differentially modulate platelet-derived growth factor-BB-induced Ca2+ signaling in transformed oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Gray matter pathology in (chronic) MS: modern views on an early observation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Central remyelination restores secure conduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Remyelination protects axons from demyelination-associated axon degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Remyelination in the CNS: from biology to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

BLBP-expression in astrocytes during experimental demyelination and in human multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Identification of a microglia phenotype supportive of remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Efficient central nervous system remyelination requires T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Electron microscopic features of multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Ultrastructure of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Multiple sclerosis. Pathology of recurrent lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Corticosteroids impair remyelination in the corpus callosum of cuprizone-treated mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Central nervous system remyelination in culture--a tool for multiple sclerosis research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

The cuprizone animal model: new insights into an old story

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Lysolecithin induces demyelination in vitro in a cerebellar slice culture system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

FTY720 modulates human oligodendrocyte progenitor process extension and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Cyclical and dose-dependent responses of adult human mature oligodendrocytes to fingolimod.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Characterization of lysophosphatidic acid and sphingosine-1-phosphate-mediated signal transduction in rat cortical oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

The immunomodulator FTY720 has a direct cytoprotective effect in oligodendrocyte progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Fingolimod modulates microglial activation to augment markers of remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Placebo controlled pilot trial to study the remyelinating potential of intravenous immunoglobulins in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

Longitudinal near-infrared imaging of myelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512438723

21 January 2018

Identifiers

DOI

10.1177/1352458512438723

1 reference

26 August 2017

1 reference

PubMed ID

22383435